Our Members

Our Objectives

LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.

Read More

Our Members

Our Members

Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.

Read More

Our Diagnosis

Our Diagnosis

Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.

Read More

Interview with Health Europe Quaterly

Stefania Vallone, LuCE president, spoke to Health Europe Quaterly about the disparities and barriers that remain in access to innovative lung cancer diagnostics, drugs, and services. The main topics were: the key barriers to faster access to treatment, diagnostic an care in Europe; how financial pressure and high costs of new drugs impact should be addressed; how important are clinical […]

Read More

Petition: Let’s reduce disparities in lung cancer: What must we do?

Lung Cancer Europe (LuCE) represents lung cancer patients and caregivers, no matter the place they live, and we advocate for the best support as possible for all of them. But, as the last report evidences, disparities in diagnosis, treatment and care access exist between different European countries, so we need solutions. We encourage our collaborators in the fields of policy, science, research and civil […]

Read More